Currently, Rocket Pharmaceuticals Inc [RCKT] is trading at $25.33, down -2.13%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The RCKT shares have gain 11.00% over the last week, with a monthly amount glided 18.98%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Rocket Pharmaceuticals Inc [NASDAQ: RCKT] stock has seen the most recent analyst activity on April 02, 2024, when Goldman initiated its Neutral rating and assigned the stock a price target of $39. Previously, Cantor Fitzgerald started tracking the stock with Overweight rating on October 24, 2023, and set its price target to $65. On February 01, 2023, Morgan Stanley initiated with a Overweight rating and assigned a price target of $45 on the stock. Canaccord Genuity started tracking the stock assigning a Buy rating and suggested a price target of $53 on November 08, 2022. BTIG Research initiated its recommendation with a Buy and recommended $35 as its price target on November 01, 2022. Raymond James started tracking with a Outperform rating for this stock on July 08, 2022, and assigned it a price target of $22.
This stock has fluctuated between a low of $14.89 and a high of $32.53 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $47.33 within the next 12 months. Rocket Pharmaceuticals Inc [NASDAQ: RCKT] shares were valued at $25.33 at the most recent close of the market. An investor can expect a potential return of 86.85% based on the average RCKT price forecast.
Analyzing the RCKT fundamentals
Gross Profit Margin for this corporation currently stands at -0.06% with Operating Profit Margin at -25.68%, Pretax Profit Margin comes in at -24.18%, and Net Profit Margin reading is -24.18%. To continue investigating profitability, this company’s Return on Assets is posted at -0.5, Equity is -0.53 and Total Capital is -0.57. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 24.78 points at the first support level, and at 24.23 for the second support level. However, for the 1st resistance point, the stock is sitting at 26.43, and for the 2nd resistance point, it is at 27.53.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Rocket Pharmaceuticals Inc [NASDAQ:RCKT] is 10.47. As well, the Quick Ratio is 10.47, while the Cash Ratio is 1.07.
Transactions by insiders
Recent insider trading involved Militello John, that happened on Jul 22 ’24 when 812.0 shares were sold., White Mark Andrew completed a deal on Jul 08 ’24 to sell 3026.0 shares. Meanwhile, CEO Shah Gaurav sold 9790.0 shares on May 16 ’24.
